Renal glomerular injury frequently results in proliferation of a speci
alized supporting cell of the glomerular capillary known as the mesang
ial cell. In various forms of renal injury there is enhanced glomerula
r synthesis of specific eicosanoids of the arachidonic cyclooxygenase
and lipoxygenase pathways including prostaglandin (PG) F-2 alpha, thro
mboxane (Tx) A(2), the hydroxyeicosatetraenoic acids 12-HETE and 5-HET
E, and the leukotrienes LTB(4) and LTD(4) and attempts have been made
to link these eicosanoids with injury-induced mesangial cell growth. I
n this study, the growth promoting effect of these eicosanoids on glom
erular mesangial cells was correlated with activation of two growth re
gulatory enzymes: phospholipase C (PLC) and protein kinase C (PKC). PG
F(2 alpha), and TxA(2) endoperoxide analog U-46619, and LTD(4) signifi
cantly enhanced DNA synthesis [(as assessed by [H-3]thymidine (TdR) in
corporation)] in relatively quiescent (0.5% serum) mesangial cells, ac
tivated PLC [as assessed by increased 1,4,5-inositol tris-phosphate (I
P3) generation and diacylglycerol (DAG) synthesis], and activated PKC
(as assessed by translocation of the enzyme activity from the cytosol
to the membrane). The effect of PGF(2 alpha) on IP3 generation was not
blocked by the TxA(2) receptor antagonist, SQ-29,548. PGF(2 alpha) wa
s the most effective eicosanoid in inducing all three events, and conc
entrations that enhanced TdR incorporation (1 mu M) also activated PLC
and PKC. In contrast, concentrations of U-46619 and LTD(4) which enha
nced TdR incorporation (1 mu M), also activated PLC, but were insuffic
ient to also activate PKC. Our observations indicate that the growth-p
romoting effect of PGF(2 alpha), U-46619, and LTD(4) can best be corre
lated with PLC activation. In addition, PGF(2 alpha) does not mediate
PLC activation through binding to the TxA(2) receptor.